All filters
Videos
New Therapeutic Combination Trials – What Are Their Potential to Achieve a Cure? - Mark Sulkowski
Presented at:
International Workshop on HBV Cure 2022
Videos
What to Watch Preclinical Therapeutics with Novel Mechanisms of Action - Massimo Levrero
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Bulevirtide - Data from Real World Usage after Approval in Europe - John Flaherty
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Development of Assembly Next Generation Core Inhibitors - Grace Wang
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Evidence of T Cell Restoration after siRNA Therapy - Emily Thi
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Cam-N Jnj-6379. Lessons Learned From Reef-1 and -2 Studies - Michael Biermer
Presented at:
International Workshop on HBV Cure 2022
Slidesets
How HBV RNA and HBcrAg Relate to cccDNA Transcriptional Activity - Barbara Testoni
Presented at:
International Workshop on HBV Cure 2022
Slidesets
HBV-Specific T Cell Profile Associated with Functional Cure - Georg Lauer
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Why We Should Be Careful Using NA Withdrawal as a Therapeutic Option - Pietro Lampertico
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Therapy Induced Flares Associated With HBsAg Decline - Man-Fung Yuen
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Toxicity Profiles of Checkpoint Inhibition, What to Expect and When to Be Concerned - Morven Cunningham
Presented at:
International Workshop on HBV Cure 2022
Slidesets
What to Watch Preclinical Therapeutics with Novel Mechanisms of Action - Massimo Levrero
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Is Therapy-Induced HBs Decline the Same as Naturally Low HBs? - Jordan Feld
Presented at:
International Workshop on HBV Cure 2022
Videos
Cam-N Jnj-6379. Lessons Learned From Reef-1 and -2 Studies - Michael Biermer
Presented at:
International Workshop on HBV Cure 2022
Videos
Toxicity Profiles of Checkpoint Inhibition, What to Expect and When to Be Concerned - M. Cunningham
Presented at:
International Workshop on HBV Cure 2022
Videos
Is Therapy-Induced HBs Decline the Same as Naturally Low HBs? - Jordan Feld
Presented at:
International Workshop on HBV Cure 2022
Videos
Bulevirtide - Data from Real World Usage after Approval in Europe - John Flaherty
Presented at:
International Workshop on HBV Cure 2022
Videos
Why We Should Be Careful Using NA Withdrawal as a Therapeutic Option - Pietro Lampertico
Presented at:
International Workshop on HBV Cure 2022
Videos
HBV-Specific T Cell Profile Associated with Functional Cure - Georg Lauer
Presented at:
International Workshop on HBV Cure 2022
Videos
How HBV RNA and HBcrAg Relate to cccDNA Transcriptional Activity - Barbara Testoni
Presented at:
International Workshop on HBV Cure 2022
Videos
Evidence of T Cell Restoration after siRNA Therapy - Emily Thi
Presented at:
International Workshop on HBV Cure 2022
Videos
Development of Assembly Next Generation Core Inhibitors - Grace Wang
Presented at:
International Workshop on HBV Cure 2022
Videos
Therapy Induced Flares Associated With HBsAg Decline - Man-Fung Yuen
Presented at:
International Workshop on HBV Cure 2022